Literature DB >> 9426326

Proposal for a new model of breast cancer metastatic development.

R Demicheli1, M W Retsky, D E Swartzendruber, G Bonadonna.   

Abstract

BACKGROUND: The commonly accepted theory of breast cancer metastatic development assumes continuous tumor growth from tumor seeding until documentation of clinical recurrence. In particular, Gompertzian growth kinetics is currently the theoretical cornerstone of the natural history of breast cancer, and has been widely utilized for planning treatments.
MATERIALS AND METHODS: To verify agreement between findings and the implications of the continuous growth model, several published papers about the natural history of breast cancer after removal of the primary tumor were reviewed. Also, findings from animal models concerning metastasis biology were considered.
RESULTS: The continuous growth model failed in important ways upon this critical reappraisal. As an alternative, the tumor dormancy hypothesis was considered to provide a more reasonable description of tumor recurrence. Moreover, primary tumor removal was revealed as a potentially perturbing factor for metastasis development.
CONCLUSIONS: A new general outline of metastatic development of breast cancer incorporating tumor dormancy in specific micrometastatic phases, stochastic transitions between them, and start signals from surgery for micrometastatic growth was designed. The proposed model suggests new views concerning scheduling of current chemotherapy, new treatment approaches aimed at keeping micrometastases in a dormant state for the patient's entire life, and the careful reappraisal of the timing of surgery within the multimodal treatment of operable breast cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9426326     DOI: 10.1023/a:1008263116022

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  31 in total

Review 1.  The dynamics of drug resistance: a mathematical perspective.

Authors:  Orit Lavi; Michael M Gottesman; Doron Levy
Journal:  Drug Resist Updat       Date:  2012-03-03       Impact factor: 18.500

Review 2.  Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.

Authors:  S E Clare; F Nakhlis; J C Panetta
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

Review 3.  Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy.

Authors:  Aparna C Ranganathan; Alejandro P Adam; Julio A Aguirre-Ghiso
Journal:  Cell Cycle       Date:  2006-08-15       Impact factor: 4.534

Review 4.  Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

Review 5.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

6.  Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis.

Authors:  Lisa M Thornton; Barbara L Andersen; William E Carson
Journal:  Cancer Immunol Immunother       Date:  2008-03-08       Impact factor: 6.968

7.  Microwave ablation of primary breast cancer inhibits metastatic progression in model mice via activation of natural killer cells.

Authors:  Muxin Yu; Hong Pan; Nan Che; Li Li; Cong Wang; Yue Wang; Ge Ma; Mengjia Qian; Jiawei Liu; Mingjie Zheng; Hui Xie; Lijun Ling; Yi Zhao; Xiaoxiang Guan; Qiang Ding; Wenbin Zhou; Shui Wang
Journal:  Cell Mol Immunol       Date:  2020-05-08       Impact factor: 11.530

8.  New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.

Authors:  Michael Retsky
Journal:  Int J Environ Res Public Health       Date:  2009-01-20       Impact factor: 3.390

9.  What can be learnt about disease progression in breast cancer dormancy from relapse data?

Authors:  Lisa Willis; Trevor A Graham; Tomás Alarcón; Malcolm R Alison; Ian P M Tomlinson; Karen M Page
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

10.  Effects of Surgery and Chemotherapy on Metastatic Progression of Prostate Cancer: Evidence from the Natural History of the Disease Reconstructed through Mathematical Modeling.

Authors:  Leonid Hanin; Marco Zaider
Journal:  Cancers (Basel)       Date:  2011-09-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.